Latest News and Press Releases

Ligand Announces Closing of Convertible Senior Notes Offering

Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering

Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030

Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance

Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025

Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™

Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics

JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at...

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025

Ligand Reports First Quarter 2025 Financial Results